Scorpion Therapeutics Patents – Insights & Stats (Updated 2023)

Scorpion Therapeutics has a total of 42 patents globally, out of which none have been granted. Of these 42 patents, more than 80% patents are active. The United States of America seems to be the main focused R&D centre and also is the origin country of Scorpion Therapeutics.

Scorpion Therapeutics was founded in 2020. Scorpion Therapeutics was formed to extend the access and effect of precision medicine to more cancer patients. The company’s product, Precision Oncology 2.0 will be delivered by integrating cutting-edge technologies in target identification, medicinal chemistry, and translational medicine.

Do read about some of the most popular patents of Scorpion Therapeutics which have been covered by us in this article and also you can find Scorpion Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Scorpion Therapeutics patent portfolio.

How many patents does Scorpion Therapeutics have?

Scorpion Therapeutics has a total of 42 patents globally. These patents belong to 13 unique patent families. Out of 42 patents, 34 patents are active.

How Many Patents did Scorpion Therapeutics File Every Year?

Scorpion Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantScorpion Therapeutics Applications FiledScorpion Therapeutics Patents Granted
202310
20226
202126

How many Scorpion Therapeutics patents are Alive/Dead?

Worldwide Patents

Scorpion Therapeutics Patent Portfolio

How Many Patents did Scorpion Therapeutics File in Different Countries?

Scorpion Therapeutics Worldwide Patent Filing

Countries in which Scorpion Therapeutics Filed Patents

CountryPatents
Argentina4
Taiwan4
Brazil2
Mexico2
Australia2
Canada2
New Zealand2
Singapore2
South Africa2
Europe2
Indonesia2
Israel2
Uruguay1
Viet Nam1

Where are Research Centers of Scorpion Therapeutics Patents Located?

R&D Centres of Scorpion Therapeutics

List of Scorpion Therapeutics patents

Scorpion Therapeutics PatentsTitle
EP4225445A2Heterocyclic Inhibitors Of Egfr And/Or Her2, For Use In The Treatment Of Cancer
EP4217070A1Pyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
WO2023183601A1Methods Of Synthesizing Egfr Inhibitors
WO2023173083A1Tetrahydroindole Derivatives As Egfr And/Or Her2 Inhibtors Useful For The Treatment Of Cancer
WO2023018636A1Compounds That Inhibit Pi3K Isoform Alpha And Methods For Treating Cancer
WO2022265993A1Urea Derivatives Which Can Be Used To Treat Cancer
CA3198202A1Methods For Treating Cancer
CA3196712A1Pyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
AU2021347288A9Pyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
AU2021358596A1Heterocyclic Inhibitors Of Egfr And/Or Her2, For Use In The Treatment Of Cancer
IL301929AHeterocyclic Inhibitors Of Egfr And/Or Her, For Use In The Treatment Of Cancer
IL301532APyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
SG11202302219RAPyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
SG11202302664SAHeterocyclic Inhibitors Of Egfr And/Or Her2, For Use In The Treatment Of Cancer
BR112023006531A2Heterocylic Egfr And/Or Her2 Inhibitors, For Use In The Treatment Of Cancer
VN97828AHeterodimeric Inhibitors Of Epidermal Growth Factor Receptor (Egfr) And/Or Human Epidermal Growth Factor Receptor 2 (Her2) And Pharmaceutical Products Containing Them
AR126147A1Urea Derivatives To Treat Cancer
ID202306098APyrolo[3,2-C]Pyridine-4-Ona Derivatives Which Are Useful In Cancer Treatment
MX2023004085AMethods For The Treatment Of Cancer
BR112023005446A2Pyrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
ID202304999AEgfr And/Or Her2 Heterosyclic Inhibitors, For Use In The Treatment Of Cancer
MX2023003362APyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
TW202317526AMethods For Treating Cancer
ZA202303873APyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
ZA202304505AHeterocyclic Inhibitors Of Egfr And/Or Her2, For Use In The Treatment Of Cancer
UY39819AMethods To Treat Cancer
AR123760A1Methods To Treat Cancer
AR123657A1Methods For The Treatment Of Cancer
AR123576A1Methods To Treat Cancer
TW202229272AMethods For Treating Cancer
TW202229282AMethods For Treating Cancer
TW202227063AMethods For Treating Cancer
NZ799055AHeterocyclic Inhibitors Of Egfr And/Or Her2, For Use In The Treatment Of Cancer
NZ798381APyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer
WO2022072645A3Pyrrolopyrolidinone And Pyrroloazepinone Derivatives For Use In Treating Cancer
WO2022197913A1Bicyclic Derivatives Which Can Be Used To Treat Cancer
WO2022076831A3Heterocyclic Inhibitors Of Egfr And/Or Her2, For Use In The Treatment Of Cancer
WO2022098992A1Use Of Macrocyclic Compounds In Methods Of Treating Cancer
WO2022094271A1Methods For Treating Cancer
WO2022072632A1Bicyclic Compounds For Use In The Treatment Cancer
WO2022072634A1Bicyclic Compounds For Use In The Treatment Cancer
WO2022066734A1Pyrrolo[3,2-C]Pyridin-4-One Derivatives Useful In The Treatment Of Cancer

What are Scorpion Therapeutics key innovation segments?

What Technologies are Covered by Scorpion Therapeutics?

The chart below distributes patents filed by Scorpion Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Scorpion Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Scorpion Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Scorpion Therapeutics?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.